N-[[3-[3-fluoro-4-(4-glycoloylpiperazin-1-yl)phenyl]-2-keto-oxazolidin-5-yl]methyl]acetamide
Compound with spectra: 1 NMR
![N-[[3-[3-fluoro-4-(4-glycoloylpiperazin-1-yl)phenyl]-2-keto-oxazolidin-5-yl]methyl]acetamide](/api/compound/FdBCh5G1wds.png?ph=true&h=300&w=458 "N-[[3-[3-fluoro-4-(4-glycoloylpiperazin-1-yl)phenyl]-2-keto-oxazolidin-5-yl]methyl]acetamide")
| SpectraBase Compound ID | FdBCh5G1wds |
|---|---|
| InChI | InChI=1S/C18H23FN4O5/c1-12(25)20-9-14-10-23(18(27)28-14)13-2-3-16(15(19)8-13)21-4-6-22(7-5-21)17(26)11-24/h2-3,8,14,24H,4-7,9-11H2,1H3,(H,20,25) |
| InChIKey | SIMWTRCFFSTNMG-UHFFFAOYSA-N |
| Mol Weight | 394.4 g/mol |
| Molecular Formula | C18H23FN4O5 |
| Exact Mass | 394.165248 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
Ethyl (2,2-dimethyl-1,3-dioxolan-4-yl)methyl(3-fluoro-4-morpholinophenyl)carbamate
Rivaroxaban TMS
ethanone, 1-[3-fluoro-4-[4-(2-fluoro-5-nitrobenzoyl)-1-piperazinyl]phenyl]-
1-propanone, 1-[4-[4-(2-chloro-4,5-difluorobenzoyl)-1-piperazinyl]-3-fluorophenyl]-
1-benzoyl-4-[4-fluoro-2-nitro-5-(1-piperidinyl)phenyl]piperazine
1-(4-methoxyphenyl)-4-[5-nitro-2-(1-pyrrolidinyl)benzoyl]piperazine
2-thiophenesulfonamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-2-oxo-1-(phenylmethyl)ethyl]-
2-thiophenesulfonamide, N-[2-[4-(5-chloro-2-methylphenyl)-1-piperazinyl]-2-oxo-1-(phenylmethyl)ethyl]-
[4-[4-fluoranyl-5-(4-methylpiperidin-1-yl)-2-nitro-phenyl]piperazin-1-yl]-phenyl-methanone
| Title | Journal or Book | Year |
|---|---|---|
| Unequivocal location of sites ofN-oxidation using natural abundance long-range1H,15N GHNMQC two-dimensional NMR | Magnetic Resonance in Chemistry | 1998 |